Delivery Order SPE2DB22D2211-SPE2DB25FRYJD
- Not listed
- The Defense Logistics Agency awarded a $5,286.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560mcg/2.24ml pens on September 8, 2025, with completion scheduled for September 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,758.48 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pens on November 4, 2025, with completion scheduled for November 5, 2025. This non-competitive delivery order represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $12,997.91 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of September 30, 2025. The contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through...
- The Defense Logistics Agency awarded a delivery order valued at $4,076.99 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pens on May 27, 2025, with an ultimate completion date of May 28, 2025. This firm fixed price, competitively awarded contract involves no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,691.54 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections, with performance in Conshohocken, Pennsylvania and completion targeted for October 30, 2025. This non-set-aside competitive award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive $999.999 billion prime vendor agreement...
- The Defense Logistics Agency awarded a delivery order valued at $4,894.36 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560 mcg/2.24 mL pen injections. The contract, which was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a firm fixed-price delivery order under a competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,569.17 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24mL pens on June 4, 2025, with an ultimate completion date of June 5, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $4,168.51 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Teriparatide 560mcg/2.24ml pens. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The award is non-set-aside and was competitively awarded. Performance will be completed by July 25,...
- The Defense Logistics Agency awarded a $5,730.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Teriparatide 560MCG/2.24ML pen injectors, with an ultimate completion date of November 5, 2025. This non-competitive delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement running through December 2026 that serves as the primary pharmaceutical supply vehicle for the Defense...
- The Defense Logistics Agency awarded a $6,226.08 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Teriparatide 560mcg/2.24ml pen injectors. The contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FRYJDDelivery Order
The Defense Logistics Agency awarded a $90,086.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Teriparatide 560 mcg/2.24 ml pens with a completion date of June 4, 2025. This contract utilizes no set-aside designation and represents a competitively awarded delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 prime vendor agreement valued through December 2026. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies. The company's DLA prime vendor contract enables comprehensive global pharmaceutical support to the Defense Health Agency and U.S. Coast Guard, among other government healthcare customers, across multiple therapeutic domains including specialty medications, brand-name and generic drugs, and medical devices. This delivery order for Teriparatide, an osteoporosis treatment medication, reflects the company's ongoing role in supplying essential pharmaceuticals to support military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $90.1k | 6/3/25 |